Geoff Meacham
Stock Analyst at Citi
(4.65)
# 820
Out of 4,411 analysts
1165
Total ratings
56%
Success rate
10.1%
Average return
Main Sectors:
Stocks Rated by Geoff Meacham
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly and Company | Maintained: Buy | $1,500 | $1,122.50 | +33.63% | 98 | Jun 16, 2026 | |
| GILD Gilead Sciences | Maintained: Buy | $165 | $127.23 | +29.69% | 79 | Jun 16, 2026 | |
| MRK Merck & Co. | Maintained: Hold | $125 | $115.17 | +8.54% | 62 | Jun 16, 2026 | |
| VRTX Vertex Pharmaceuticals | Maintained: Buy | $585 | $453.17 | +29.09% | 64 | Jun 16, 2026 | |
| ABBV AbbVie | Maintained: Hold | $230 | $222.47 | +3.38% | 64 | Jun 12, 2026 | |
| FTH Faeth Therapeutics | Maintained: Buy | $55 | $14.42 | +281.55% | 2 | Jun 11, 2026 | |
| PFE Pfizer | Maintained: Hold | $27 | $26.04 | +3.69% | 72 | Jun 7, 2026 | |
| BMY Bristol-Myers Squibb Company | Maintained: Hold | $66 | $55.92 | +18.03% | 70 | May 31, 2026 | |
| APGE Apogee Therapeutics | Maintained: Buy | $125 | $85.24 | +46.64% | 14 | May 28, 2026 | |
| RPRX Royalty Pharma | Maintained: Buy | $66 | $54.21 | +21.75% | 25 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $900 → $700 | $614.73 | +13.87% | 57 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $120 → $135 | $90.95 | +48.43% | 5 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $130 | $110.64 | +17.50% | 11 | May 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $7 | $9.20 | -23.91% | 7 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $75 | $73.27 | +2.36% | 16 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $58 | $45.56 | +27.30% | 5 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $15.05 | +32.89% | 19 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $190 → $200 | $195.61 | +2.24% | 70 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $345 | $347.84 | -0.82% | 43 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $120 | $87.44 | +37.24% | 17 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 → $60 | $52.30 | +14.72% | 17 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $145 → $130 | $89.50 | +45.25% | 15 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $41 | $55.40 | -25.99% | 57 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 | $14.11 | +254.36% | 2 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $55 | $30.26 | +81.76% | 4 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $2.29 | +74.67% | 10 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $170 | $235.18 | n/a | 33 | Jun 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $1.56 | n/a | 3 | Jun 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $130 | $55.12 | n/a | 35 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $1.69 | n/a | 8 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 | $52.02 | n/a | 8 | May 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $14 | $2.83 | n/a | 6 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $9 | $12.44 | n/a | 3 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 | $23.99 | n/a | 1 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $101 | $49.31 | n/a | 1 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.7597 | n/a | 4 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $23 → $15 | $28.16 | n/a | 4 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $52.22 | n/a | 1 | Oct 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.18 | n/a | 4 | Sep 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $23 → $14 | $8.61 | n/a | 4 | Sep 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $25 | $13.70 | n/a | 2 | Jul 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $68.01 | n/a | 1 | Mar 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $18 | $66.64 | n/a | 6 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $23 | $23.55 | n/a | 1 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $8 → $2 | $6.52 | n/a | 3 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $80 → $150 | $548.27 | n/a | 15 | Feb 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $15 → $16 | $2.36 | n/a | 2 | Feb 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $49 | $75.21 | n/a | 1 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $2 → $24 | $1.11 | n/a | 6 | Feb 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $83 → $44 | $1.20 | n/a | 5 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $12 → $4 | $9.48 | n/a | 5 | Jun 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 → $62 | $1.08 | n/a | 3 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 → $20 | $13.38 | n/a | 2 | May 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $6.93 | n/a | 1 | Jan 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $49 → $75 | $8.29 | n/a | 10 | Oct 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $1.09 | n/a | 1 | Jun 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 | $29.47 | n/a | 1 | Mar 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $55 → $35 | $3.16 | n/a | 3 | Jan 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $70 | $2.80 | n/a | 1 | Jan 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $8.92 | n/a | 1 | Dec 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 | $20.59 | n/a | 1 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $0.17 | n/a | 1 | Sep 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $30 | $12.75 | n/a | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $20 → $19 | $53.38 | n/a | 3 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €77.60 | $132.05 | n/a | 1 | Feb 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $27 → $32 | $0.1677 | n/a | 3 | Dec 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $90 → $82 | $99.75 | n/a | 15 | May 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $13 → $13 | $3.66 | n/a | 9 | May 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8 | $16.75 | n/a | 3 | Mar 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 | $1.54 | n/a | 2 | Mar 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $103 → $110 | $156.42 | n/a | 11 | Mar 28, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $2.93 | n/a | 1 | Mar 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $6.93 | n/a | 6 | Feb 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $80 → $105 | $281.90 | n/a | 8 | Sep 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Sell | $20 → $8 | $22.49 | n/a | 2 | Sep 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $25 → $16 | $12.03 | n/a | 2 | Oct 23, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $60 → $90 | $31.85 | n/a | 5 | Dec 2, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $13.27 | n/a | 1 | Sep 17, 2012 |
Eli Lilly and Company
Jun 16, 2026
Maintained: Buy
Price Target: $1,500
Current: $1,122.50
Upside: +33.63%
Gilead Sciences
Jun 16, 2026
Maintained: Buy
Price Target: $165
Current: $127.23
Upside: +29.69%
Merck & Co.
Jun 16, 2026
Maintained: Hold
Price Target: $125
Current: $115.17
Upside: +8.54%
Vertex Pharmaceuticals
Jun 16, 2026
Maintained: Buy
Price Target: $585
Current: $453.17
Upside: +29.09%
AbbVie
Jun 12, 2026
Maintained: Hold
Price Target: $230
Current: $222.47
Upside: +3.38%
Faeth Therapeutics
Jun 11, 2026
Maintained: Buy
Price Target: $55
Current: $14.42
Upside: +281.55%
Pfizer
Jun 7, 2026
Maintained: Hold
Price Target: $27
Current: $26.04
Upside: +3.69%
Bristol-Myers Squibb Company
May 31, 2026
Maintained: Hold
Price Target: $66
Current: $55.92
Upside: +18.03%
Apogee Therapeutics
May 28, 2026
Maintained: Buy
Price Target: $125
Current: $85.24
Upside: +46.64%
Royalty Pharma
May 26, 2026
Maintained: Buy
Price Target: $66
Current: $54.21
Upside: +21.75%
May 18, 2026
Downgraded: Hold
Price Target: $900 → $700
Current: $614.73
Upside: +13.87%
May 18, 2026
Maintained: Buy
Price Target: $120 → $135
Current: $90.95
Upside: +48.43%
May 10, 2026
Maintained: Buy
Price Target: $130
Current: $110.64
Upside: +17.50%
May 7, 2026
Maintained: Sell
Price Target: $7
Current: $9.20
Upside: -23.91%
May 7, 2026
Maintained: Hold
Price Target: $75
Current: $73.27
Upside: +2.36%
May 7, 2026
Maintained: Buy
Price Target: $58
Current: $45.56
Upside: +27.30%
May 7, 2026
Maintained: Buy
Price Target: $20
Current: $15.05
Upside: +32.89%
May 4, 2026
Rated: Hold
Price Target: $190 → $200
Current: $195.61
Upside: +2.24%
May 1, 2026
Maintained: Hold
Price Target: $345
Current: $347.84
Upside: -0.82%
Apr 30, 2026
Maintained: Buy
Price Target: $120
Current: $87.44
Upside: +37.24%
Apr 29, 2026
Maintained: Buy
Price Target: $50 → $60
Current: $52.30
Upside: +14.72%
Mar 11, 2026
Maintained: Buy
Price Target: $145 → $130
Current: $89.50
Upside: +45.25%
Mar 3, 2026
Maintained: Hold
Price Target: $41
Current: $55.40
Upside: -25.99%
Jan 30, 2026
Maintained: Buy
Price Target: $50
Current: $14.11
Upside: +254.36%
Jan 30, 2026
Maintained: Buy
Price Target: $55
Current: $30.26
Upside: +81.76%
Jan 30, 2026
Maintained: Buy
Price Target: $4
Current: $2.29
Upside: +74.67%
Jun 10, 2024
Maintained: Hold
Price Target: $170
Current: $235.18
Upside: n/a
Jun 6, 2024
Maintained: Buy
Price Target: $22
Current: $1.56
Upside: n/a
Jun 4, 2024
Maintained: Buy
Price Target: $130
Current: $55.12
Upside: n/a
Jun 3, 2024
Reiterated: Buy
Price Target: $17
Current: $1.69
Upside: n/a
May 23, 2024
Maintained: Buy
Price Target: $100
Current: $52.02
Upside: n/a
May 13, 2024
Reiterated: Buy
Price Target: $10 → $14
Current: $2.83
Upside: n/a
May 13, 2024
Maintained: Buy
Price Target: $14 → $9
Current: $12.44
Upside: n/a
May 13, 2024
Maintained: Buy
Price Target: $36
Current: $23.99
Upside: n/a
May 10, 2024
Maintained: Buy
Price Target: $101
Current: $49.31
Upside: n/a
Mar 15, 2024
Rated: Hold
Price Target: n/a
Current: $0.7597
Upside: n/a
Dec 15, 2023
Downgraded: Hold
Price Target: $23 → $15
Current: $28.16
Upside: n/a
Oct 11, 2023
Maintained: Sell
Price Target: n/a
Current: $52.22
Upside: n/a
Sep 29, 2023
Rated: Hold
Price Target: n/a
Current: $2.18
Upside: n/a
Sep 8, 2023
Downgraded: Hold
Price Target: $23 → $14
Current: $8.61
Upside: n/a
Jul 18, 2023
Reiterated: Buy
Price Target: $35 → $25
Current: $13.70
Upside: n/a
Mar 16, 2023
Reiterated: Buy
Price Target: $13
Current: $68.01
Upside: n/a
Mar 6, 2023
Reiterated: Buy
Price Target: $13 → $18
Current: $66.64
Upside: n/a
Feb 28, 2023
Reiterated: Hold
Price Target: $23
Current: $23.55
Upside: n/a
Feb 23, 2023
Downgraded: Sell
Price Target: $8 → $2
Current: $6.52
Upside: n/a
Feb 22, 2023
Reiterated: Sell
Price Target: $80 → $150
Current: $548.27
Upside: n/a
Feb 22, 2023
Reiterated: Hold
Price Target: $15 → $16
Current: $2.36
Upside: n/a
Feb 17, 2023
Initiated Coverage: Hold
Price Target: $49
Current: $75.21
Upside: n/a
Feb 16, 2023
Reiterated: Sell
Price Target: $2 → $24
Current: $1.11
Upside: n/a
Nov 14, 2022
Maintained: Buy
Price Target: $83 → $44
Current: $1.20
Upside: n/a
Jun 8, 2022
Downgraded: Hold
Price Target: $12 → $4
Current: $9.48
Upside: n/a
May 18, 2022
Reiterated: Buy
Price Target: $75 → $62
Current: $1.08
Upside: n/a
May 17, 2022
Maintained: Buy
Price Target: $28 → $20
Current: $13.38
Upside: n/a
Jan 13, 2022
Reiterated: Buy
Price Target: $60
Current: $6.93
Upside: n/a
Oct 8, 2021
Maintained: Hold
Price Target: $49 → $75
Current: $8.29
Upside: n/a
Jun 8, 2021
Upgraded: Hold
Price Target: n/a
Current: $1.09
Upside: n/a
Mar 19, 2021
Maintained: Buy
Price Target: $35
Current: $29.47
Upside: n/a
Jan 15, 2021
Downgraded: Hold
Price Target: $55 → $35
Current: $3.16
Upside: n/a
Jan 5, 2021
Maintained: Buy
Price Target: $70
Current: $2.80
Upside: n/a
Dec 7, 2020
Reiterated: Buy
Price Target: $9
Current: $8.92
Upside: n/a
Nov 23, 2020
Initiated Coverage: Buy
Price Target: $21
Current: $20.59
Upside: n/a
Sep 8, 2020
Initiated Coverage: Buy
Price Target: $20
Current: $0.17
Upside: n/a
Jun 25, 2020
Initiated Coverage: Buy
Price Target: $30
Current: $12.75
Upside: n/a
Feb 25, 2020
Downgraded: Hold
Price Target: $20 → $19
Current: $53.38
Upside: n/a
Feb 20, 2020
Maintained: Hold
Price Target: €77.60
Current: $132.05
Upside: n/a
Dec 3, 2019
Initiated Coverage: Buy
Price Target: $27 → $32
Current: $0.1677
Upside: n/a
May 3, 2019
Downgraded: Hold
Price Target: $90 → $82
Current: $99.75
Upside: n/a
May 2, 2019
Maintained: Hold
Price Target: $13 → $13
Current: $3.66
Upside: n/a
Mar 29, 2019
Maintained: Hold
Price Target: $8
Current: $16.75
Upside: n/a
Mar 29, 2019
Maintained: Buy
Price Target: $27
Current: $1.54
Upside: n/a
Mar 28, 2019
Maintained: Buy
Price Target: $103 → $110
Current: $156.42
Upside: n/a
Mar 11, 2019
Initiated Coverage: Buy
Price Target: $16
Current: $2.93
Upside: n/a
Feb 20, 2019
Maintained: Buy
Price Target: n/a
Current: $6.93
Upside: n/a
Sep 7, 2017
Rated: Buy
Price Target: $80 → $105
Current: $281.90
Upside: n/a
Sep 7, 2017
Rated: Sell
Price Target: $20 → $8
Current: $22.49
Upside: n/a
Oct 23, 2015
Downgraded: Sell
Price Target: $25 → $16
Current: $12.03
Upside: n/a
Dec 2, 2014
Downgraded: Hold
Price Target: $60 → $90
Current: $31.85
Upside: n/a
Sep 17, 2012
Downgraded: Hold
Price Target: n/a
Current: $13.27
Upside: n/a